Cargando…
P977: THE VENOUS THROMBOEMBOLISM RISK ASSESMENT MODELS IN MULTIPLE MYELOMA
Autores principales: | Alp Kirkizlar, Tugcan, Kirkizlar, Onur, Muzaffer Demir, Ahmet, Gulsum Umit, Elif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431373/ http://dx.doi.org/10.1097/01.HS9.0000970812.20451.72 |
Ejemplares similares
-
Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey
por: Umit, Elif Gulsum, et al.
Publicado: (2020) -
Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia
por: Baysal, Mehmet, et al.
Publicado: (2021) -
Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?
por: Baysal, Mehmet, et al.
Publicado: (2022) -
Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
por: Baysal, Mehmet, et al.
Publicado: (2020) -
Fusarium Endophthalmitis, Unusual and Challenging Infection in an Acute Leukemia Patient
por: Baysal, Mehmet, et al.
Publicado: (2018)